DocSym
β
Searchsearch
Search
(J84.9) Interstitial pulmonary disease, unspecified
More details coming soon
2 362 202 in individuals diagnosis interstitial pulmonary disease, unspecified confirmed
381 524 deaths with diagnosis interstitial pulmonary disease, unspecified
16% mortality rate associated with the disease interstitial pulmonary disease, unspecified
Diagnosis interstitial pulmonary disease, unspecified is diagnosed Men are 4.97% more likely than Women
1 239 803
Men receive the diagnosis interstitial pulmonary disease, unspecified
230 201 (18.6 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
1 122 399
Women receive the diagnosis interstitial pulmonary disease, unspecified
151 323 (13.5 %)Died from this diagnosis.
Risk Group for the Disease interstitial pulmonary disease, unspecified - Men aged 65-69 and Women aged 60-64
In Men diagnosis is most often set at age 0-95+
in in men, the disease manifests at any agein in women, the disease manifests at any age
In Women diagnosis is most often set at age 0-95+
Disease Features interstitial pulmonary disease, unspecified
Absence or low individual and public risk
Interstitial pulmonary disease, unspecified - what does this mean
Interstitial pulmonary disease, unspecified is a group of lung diseases that cause scarring of the lung tissue, resulting in difficulty breathing. this can be caused by a variety of factors, such as exposure to irritants, infections, and autoimmune disorders. it can also be caused by certain medications or radiation therapy. symptoms can include shortness of breath, chest pain, and a dry cough. treatment is based on the underlying cause and may include medications, oxygen therapy, and lifestyle changes.
What happens during the disease - interstitial pulmonary disease, unspecified
Interstitial pulmonary disease is a group of disorders characterized by inflammation and/or scarring of the interstitial tissue of the lungs, which is the tissue that surrounds the air sacs. this inflammation and/or scarring can lead to a decrease in the elasticity of the lungs, making it difficult for the lungs to expand and fill with air, resulting in decreased oxygen levels in the blood. this can lead to a variety of symptoms, such as shortness of breath, wheezing, chest tightness, fatigue, and coughing. the exact cause of interstitial pulmonary disease is unknown, but it is thought to be related to environmental factors, genetic predisposition, and/or autoimmune disorders.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Chest X-ray
- Pulmonary function tests
- High-resolution computed tomography (HRCT) scan
- Bronchoalveolar lavage
- Spirometry
- Arterial blood gas analysis
- Pulse oximetry
- Exercise testing
- Lung biopsy
Treatment and Medical Assistance
Main goal of the treatment: To reduce the symptoms of Interstitial Pulmonary Disease (IPD) and improve overall quality of life.
- Identifying and avoiding environmental triggers of IPD
- Quitting smoking
- Using medication to reduce inflammation in the lungs
- Using supplemental oxygen therapy
- Using pulmonary rehabilitation to improve breathing
- Surgery to remove damaged tissue or scarring
- Using immunosuppressant drugs to reduce inflammation
- Using antibiotics to treat infections
- Using corticosteroids to reduce inflammation
- Using antifibrotic drugs to reduce scarring
18 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Interstitial pulmonary disease, unspecified - Prevention
Interstitial pulmonary disease, unspecified can be prevented by avoiding smoking, reducing exposure to air pollution, and avoiding environmental irritants such as dust and fumes. additionally, it is important to get vaccinated against any infections that could lead to interstitial lung disease, and to seek medical attention for any respiratory symptoms.